Kaitai Biotechnology

Kaitai Biotechnology is a synthetic biology company headquartered in Suzhou, China, focused on the development of next-generation enzymatic DNA synthesis (EDS) technologies. The company aims to replace traditional phosphoramidite chemical synthesis methods with a high-throughput, automated platform that produces long-strand DNA and RNA with high fidelity and lower environmental impact. Kaitai's technology supports a wide range of applications, including gene synthesis, molecular diagnostics, DNA-based data storage, and the development of nucleic acid-based therapeutics. By leveraging expertise in protein engineering and microfluidics, the company is positioning itself as a key infrastructure provider for the global biotechnology industry.